The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Methotrexate-Global Market Insights and Sales Trends 2025
Synopsis
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
The global Methotrexate market size is expected to reach US$ 624.6 million by 2029, growing at a CAGR of 2.7% from 2023 to 2029. The market is mainly driven by the significant applications of Methotrexate in various end use industries. The expanding demands from the Used for Cancers, Used for Rheumatoid Arthritis and Used for Other Diseases,, are propelling Methotrexate market. Methotrexate for Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Methotrexate Tablets segment is estimated at % CAGR for the next seven-year period.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Methotrexate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Methotrexate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Methotrexate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Methotrexate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Methotrexate covered in this report include Teva Pharmaceutical Industries, Qualitestrx (DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone and Huiyu, etc.
The global Methotrexate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Global Methotrexate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Methotrexate market, Segment by Type:
Methotrexate for Injection
Methotrexate Tablets
Global Methotrexate market, by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Methotrexate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
The global Methotrexate market size is expected to reach US$ 624.6 million by 2029, growing at a CAGR of 2.7% from 2023 to 2029. The market is mainly driven by the significant applications of Methotrexate in various end use industries. The expanding demands from the Used for Cancers, Used for Rheumatoid Arthritis and Used for Other Diseases,, are propelling Methotrexate market. Methotrexate for Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Methotrexate Tablets segment is estimated at % CAGR for the next seven-year period.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Methotrexate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Methotrexate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Methotrexate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Methotrexate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Methotrexate covered in this report include Teva Pharmaceutical Industries, Qualitestrx (DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone and Huiyu, etc.
The global Methotrexate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Global Methotrexate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Methotrexate market, Segment by Type:
Methotrexate for Injection
Methotrexate Tablets
Global Methotrexate market, by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Methotrexate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Methotrexate Market Overview
1.1 Methotrexate Product Overview
1.2 Methotrexate Market Segment by Type
1.2.1 Methotrexate for Injection
1.2.2 Methotrexate Tablets
1.3 Global Methotrexate Market Size by Type
1.3.1 Global Methotrexate Market Size Overview by Type (2018-2029)
1.3.2 Global Methotrexate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Methotrexate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Methotrexate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Methotrexate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Methotrexate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Methotrexate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Methotrexate Sales Breakdown by Type (2018-2023)
2 Global Methotrexate Market Competition by Company
2.1 Global Top Players by Methotrexate Sales (2018-2023)
2.2 Global Top Players by Methotrexate Revenue (2018-2023)
2.3 Global Top Players by Methotrexate Price (2018-2023)
2.4 Global Top Manufacturers Methotrexate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Methotrexate Market Competitive Situation and Trends
2.5.1 Methotrexate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Methotrexate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Methotrexate as of 2022)
2.7 Date of Key Manufacturers Enter into Methotrexate Market
2.8 Key Manufacturers Methotrexate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Methotrexate Status and Outlook by Region
3.1 Global Methotrexate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Methotrexate Historic Market Size by Region
3.2.1 Global Methotrexate Sales in Volume by Region (2018-2023)
3.2.2 Global Methotrexate Sales in Value by Region (2018-2023)
3.2.3 Global Methotrexate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Methotrexate Forecasted Market Size by Region
3.3.1 Global Methotrexate Sales in Volume by Region (2024-2029)
3.3.2 Global Methotrexate Sales in Value by Region (2024-2029)
3.3.3 Global Methotrexate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Methotrexate by Application
4.1 Methotrexate Market Segment by Application
4.1.1 Used for Cancers
4.1.2 Used for Rheumatoid Arthritis
4.1.3 Used for Other Diseases
4.2 Global Methotrexate Market Size by Application
4.2.1 Global Methotrexate Market Size Overview by Application (2018-2029)
4.2.2 Global Methotrexate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Methotrexate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Methotrexate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Methotrexate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Methotrexate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Methotrexate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Methotrexate Sales Breakdown by Application (2018-2023)
5 North America Methotrexate by Country
5.1 North America Methotrexate Historic Market Size by Country
5.1.1 North America Methotrexate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Methotrexate Sales in Volume by Country (2018-2023)
5.1.3 North America Methotrexate Sales in Value by Country (2018-2023)
5.2 North America Methotrexate Forecasted Market Size by Country
5.2.1 North America Methotrexate Sales in Volume by Country (2024-2029)
5.2.2 North America Methotrexate Sales in Value by Country (2024-2029)
6 Europe Methotrexate by Country
6.1 Europe Methotrexate Historic Market Size by Country
6.1.1 Europe Methotrexate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Methotrexate Sales in Volume by Country (2018-2023)
6.1.3 Europe Methotrexate Sales in Value by Country (2018-2023)
6.2 Europe Methotrexate Forecasted Market Size by Country
6.2.1 Europe Methotrexate Sales in Volume by Country (2024-2029)
6.2.2 Europe Methotrexate Sales in Value by Country (2024-2029)
7 Asia-Pacific Methotrexate by Region
7.1 Asia-Pacific Methotrexate Historic Market Size by Region
7.1.1 Asia-Pacific Methotrexate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Methotrexate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Methotrexate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Methotrexate Forecasted Market Size by Region
7.2.1 Asia-Pacific Methotrexate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Methotrexate Sales in Value by Region (2024-2029)
8 Latin America Methotrexate by Country
8.1 Latin America Methotrexate Historic Market Size by Country
8.1.1 Latin America Methotrexate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Methotrexate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Methotrexate Sales in Value by Country (2018-2023)
8.2 Latin America Methotrexate Forecasted Market Size by Country
8.2.1 Latin America Methotrexate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Methotrexate Sales in Value by Country (2024-2029)
9 Middle East and Africa Methotrexate by Country
9.1 Middle East and Africa Methotrexate Historic Market Size by Country
9.1.1 Middle East and Africa Methotrexate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Methotrexate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Methotrexate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Methotrexate Forecasted Market Size by Country
9.2.1 Middle East and Africa Methotrexate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Methotrexate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva Pharmaceutical Industries
10.1.1 Teva Pharmaceutical Industries Company Information
10.1.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Pharmaceutical Industries Methotrexate Products Offered
10.1.5 Teva Pharmaceutical Industries Recent Development
10.2 Qualitestrx (DAVA Pharmaceuticals)
10.2.1 Qualitestrx (DAVA Pharmaceuticals) Company Information
10.2.2 Qualitestrx (DAVA Pharmaceuticals) Introduction and Business Overview
10.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Products Offered
10.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Development
10.3 Pfizer (Hospira)
10.3.1 Pfizer (Hospira) Company Information
10.3.2 Pfizer (Hospira) Introduction and Business Overview
10.3.3 Pfizer (Hospira) Methotrexate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer (Hospira) Methotrexate Products Offered
10.3.5 Pfizer (Hospira) Recent Development
10.4 Roxane Laboratories
10.4.1 Roxane Laboratories Company Information
10.4.2 Roxane Laboratories Introduction and Business Overview
10.4.3 Roxane Laboratories Methotrexate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Roxane Laboratories Methotrexate Products Offered
10.4.5 Roxane Laboratories Recent Development
10.5 Sine
10.5.1 Sine Company Information
10.5.2 Sine Introduction and Business Overview
10.5.3 Sine Methotrexate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sine Methotrexate Products Offered
10.5.5 Sine Recent Development
10.6 Maoxiang
10.6.1 Maoxiang Company Information
10.6.2 Maoxiang Introduction and Business Overview
10.6.3 Maoxiang Methotrexate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Maoxiang Methotrexate Products Offered
10.6.5 Maoxiang Recent Development
10.7 LingNan Pharmaceutical
10.7.1 LingNan Pharmaceutical Company Information
10.7.2 LingNan Pharmaceutical Introduction and Business Overview
10.7.3 LingNan Pharmaceutical Methotrexate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 LingNan Pharmaceutical Methotrexate Products Offered
10.7.5 LingNan Pharmaceutical Recent Development
10.8 Powerdone
10.8.1 Powerdone Company Information
10.8.2 Powerdone Introduction and Business Overview
10.8.3 Powerdone Methotrexate Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Powerdone Methotrexate Products Offered
10.8.5 Powerdone Recent Development
10.9 Huiyu
10.9.1 Huiyu Company Information
10.9.2 Huiyu Introduction and Business Overview
10.9.3 Huiyu Methotrexate Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Huiyu Methotrexate Products Offered
10.9.5 Huiyu Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Methotrexate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Methotrexate Industrial Chain Analysis
11.4 Methotrexate Market Dynamics
11.4.1 Methotrexate Industry Trends
11.4.2 Methotrexate Market Drivers
11.4.3 Methotrexate Market Challenges
11.4.4 Methotrexate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Methotrexate Distributors
12.3 Methotrexate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
